Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Bloomquist EW"'
Publikováno v:
Biostatistics; Jan2009, Vol. 10 Issue 1, p106-120, 15p
Autor:
Maguire WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bulik CC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Agrawal S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hamed SS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2011-2016.
Autor:
Gao JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Osgood CL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Feng Z; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang CJG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ricks TK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hou SC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5008-5011.
Autor:
Vellanki PJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA Paz.Vellanki@fda.hhs.gov., Ghosh S; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA., Pathak A; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA., Fusco MJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Bloomquist EW; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Tang S; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Singh H; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Philip R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA., Beaver JA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).
Autor:
Fallah J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Brave MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mehta GU; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gittleman H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hamed SS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dorff SE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chambers WA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Mixter BD; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Dinin J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ricks TK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Donoghue M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ibrahim A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Nov 14; Vol. 28 (22), pp. 4843-4848.
Autor:
Arora S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Narayan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ison G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Berman T; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Wedam S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Prowell TM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ghosh S; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Philip R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Osgood CL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Shah M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Krol D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Wahby S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Royce M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Brus C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Ibrahim A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 15; Vol. 28 (6), pp. 1058-1071.
Autor:
Arora S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Narayan P; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Osgood CL; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Wedam S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Prowell TM; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Gao JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Shah M; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Krol D; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Wahby S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Royce M; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Ghosh S; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Philip R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Ison G; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Berman T; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Brus C; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Ibrahim A; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 15; Vol. 28 (6), pp. 1072-1086.
Autor:
Amatya AK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland. anup.amatya@fda.hhs.gov., Fiero MH; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Bloomquist EW; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Sinha AK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland., Lemery SJ; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Singh H; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Ibrahim A; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Donoghue M; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Fashoyin-Aje LA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., de Claro RA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Gormley NJ; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Amiri-Kordestani L; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Sridhara R; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Theoret MR; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Kluetz PG; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Pazdur R; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Beaver JA; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Silver Spring, Maryland.; US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland., Tang S; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biostatistics, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5753-5756. Date of Electronic Publication: 2021 Jun 11.
Autor:
Gao JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland. jennifer.gao@fda.hhs.gov., Osgood CL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gong Y; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Zhang H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bloomquist EW; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jiang X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Qiu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Song P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rahman NA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chiu HJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ricks TK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rizvi F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hou S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Wilson W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Abukhdeir AM; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Seidman J; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Ghosh S; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Philip R; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Apr 15; Vol. 27 (8), pp. 2126-2129. Date of Electronic Publication: 2020 Nov 13.
Autor:
Brewer JR; U.S. Food and Drug Administration, White Oak, Maryland. Jamie.Brewer@fda.hhs.gov., Chang E; U.S. Food and Drug Administration, White Oak, Maryland., Agrawal S; U.S. Food and Drug Administration, White Oak, Maryland., Singh H; U.S. Food and Drug Administration, White Oak, Maryland., Suzman DL; U.S. Food and Drug Administration, White Oak, Maryland., Xu J; U.S. Food and Drug Administration, White Oak, Maryland., Weinstock C; U.S. Food and Drug Administration, White Oak, Maryland., Fernandes LL; U.S. Food and Drug Administration, White Oak, Maryland., Cheng J; U.S. Food and Drug Administration, White Oak, Maryland., Zhang L; U.S. Food and Drug Administration, White Oak, Maryland., Xie D; U.S. Food and Drug Administration, White Oak, Maryland., Goldberg KB; U.S. Food and Drug Administration, White Oak, Maryland., Bloomquist EW; U.S. Food and Drug Administration, White Oak, Maryland., Tang S; U.S. Food and Drug Administration, White Oak, Maryland., Sridhara R; U.S. Food and Drug Administration, White Oak, Maryland., Theoret MR; U.S. Food and Drug Administration, White Oak, Maryland., Pazdur R; U.S. Food and Drug Administration, White Oak, Maryland., Ibrahim A; U.S. Food and Drug Administration, White Oak, Maryland., Beaver JA; U.S. Food and Drug Administration, White Oak, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 15; Vol. 26 (24), pp. 6406-6411. Date of Electronic Publication: 2020 Jul 30.